Skip to main content
Top
Published in: Head & Neck Oncology 1/2012

Open Access 01-12-2012 | Research

Structural validation of oral mucosal tissue using optical coherence tomography

Authors: Zaid Hamdoon, Waseem Jerjes, Raed Al-Delayme, Gordon McKenzie, Amrita Jay, Colin Hopper

Published in: Head & Neck Oncology | Issue 1/2012

Login to get access

Abstract

Background

Optical coherence tomography (OCT) is a non-invasive optical technology using near-infrared light to produce cross-sectional tissue images with lateral resolution.

Objectives

The overall aims of this study was to generate a bank of normative and pathological OCT data of the oral tissues to allow identification of cellular structures of normal and pathological processes with the aim to create a diagnostic algorithm which can be used in the early detection of oral disorders.

Material and methods

Seventy-three patients with 78 suspicious oral lesions were referred for further management to the UCLH Head and Neck Centre, London. The entire cohort had their lesions surgically biopsied (incisional or excisional). The immediate ex vivo phase involved scanning the specimens using optical coherence tomography. The specimens were then processed by a histopathologist.
Five tissue structures were evaluated as part of this study, including: keratin cell layer, epithelial layer, basement membrane, lamina propria and other microanatomical structures. Two independent assessors (clinician and pathologist trained to use OCT) assessed the OCT images and were asked to comment on the cellular structures and changes involving the five tissue structures in non-blind fashion.

Results

Correct identification of the keratin cell layer and its structural changes was achieved in 87% of the cohort; for the epithelial layer it reached 93.5%, and 94% for the basement membrane. Microanatomical structures identification was 64% for blood vessels, 58% for salivary gland ducts and 89% for rete pegs. The agreement was “good” between the clinician and the pathologist.
OCT was able to differential normal from pathological tissue and pathological tissue of different entities in this immediate ex vivo study. Unfortunately, OCT provided inadequate cellular and subcellular information to enable the grading of oral premalignant disorders.

Conclusion

This study enabled the creation of OCT bank of normal and pathological oral tissues. The pathological changes identified using OCT enabled differentiation between normal and pathological tissues, and identification of different tissue pathologies.
Further studies are required to assess the accuracy of OCT in identification of various pathological processes involving the oral tissues.
Appendix
Available only for authorised users
Literature
1.
go back to reference Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, Biel MA, Bigio I, Wong BJ, Gillenwater A, MacRobert AJ, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Mosse CA, Barr H, Chen Z, Berg K, D’Cruz AK, Stone N, Kendall C, Fisher S, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Yodh AG, Hopper C: Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol. 2009 Jul 13, 1: 25-10.1186/1758-3284-1-25.PubMedCentralCrossRefPubMed Upile T, Jerjes W, Sterenborg HJ, El-Naggar AK, Sandison A, Witjes MJ, Biel MA, Bigio I, Wong BJ, Gillenwater A, MacRobert AJ, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Mosse CA, Barr H, Chen Z, Berg K, D’Cruz AK, Stone N, Kendall C, Fisher S, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Yodh AG, Hopper C: Head & neck optical diagnostics: vision of the future of surgery. Head Neck Oncol. 2009 Jul 13, 1: 25-10.1186/1758-3284-1-25.PubMedCentralCrossRefPubMed
2.
go back to reference Upile T, Jerjes WK, Sterenborg HJ, Wong BJ, El-Naggar AK, Ilgner JF, Sandison A, Witjes MJ, Biel MA, van Veen R, Hamdoon Z, Gillenwater A, Mosse CA, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Barr H, Chen Z, Berg K, D’Cruz AK, Sudhoff H, Stone N, Kendall C, Fisher S, MacRobert AJ, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Bigio I, Yodh AG, Hopper C: At the frontiers of surgery: review. Head Neck Oncol. 2011 Feb 9, 3 (1): 7-10.1186/1758-3284-3-7.PubMedCentralCrossRefPubMed Upile T, Jerjes WK, Sterenborg HJ, Wong BJ, El-Naggar AK, Ilgner JF, Sandison A, Witjes MJ, Biel MA, van Veen R, Hamdoon Z, Gillenwater A, Mosse CA, Robinson DJ, Betz CS, Stepp H, Bolotine L, McKenzie G, Barr H, Chen Z, Berg K, D’Cruz AK, Sudhoff H, Stone N, Kendall C, Fisher S, MacRobert AJ, Leunig A, Olivo M, Richards-Kortum R, Soo KC, Bagnato V, Choo-Smith LP, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Bigio I, Yodh AG, Hopper C: At the frontiers of surgery: review. Head Neck Oncol. 2011 Feb 9, 3 (1): 7-10.1186/1758-3284-3-7.PubMedCentralCrossRefPubMed
3.
go back to reference Jerjes WK, Upile T, Wong BJ, Betz CS, Sterenborg HJ, Witjes MJ, Berg K, van Veen R, Biel MA, El-Naggar AK, Mosse CA, Olivo M, Richards-Kortum R, Robinson DJ, Rosen J, Yodh AG, Kendall C, Ilgner JF, Amelink A, Bagnato V, Barr H, Bolotine L, Bigio I, Chen Z, Choo-Smith LP, D’Cruz AK, Gillenwater A, Leunig A, MacRobert AJ, McKenzie G, Sandison A, Soo KC, Stepp H, Stone N, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Hopper C: The future of medical diagnostics: review paper. Head Neck Oncol. 2011 Aug 23, 3: 38-10.1186/1758-3284-3-38.PubMedCentralCrossRefPubMed Jerjes WK, Upile T, Wong BJ, Betz CS, Sterenborg HJ, Witjes MJ, Berg K, van Veen R, Biel MA, El-Naggar AK, Mosse CA, Olivo M, Richards-Kortum R, Robinson DJ, Rosen J, Yodh AG, Kendall C, Ilgner JF, Amelink A, Bagnato V, Barr H, Bolotine L, Bigio I, Chen Z, Choo-Smith LP, D’Cruz AK, Gillenwater A, Leunig A, MacRobert AJ, McKenzie G, Sandison A, Soo KC, Stepp H, Stone N, Svanberg K, Tan IB, Wilson BC, Wolfsen H, Hopper C: The future of medical diagnostics: review paper. Head Neck Oncol. 2011 Aug 23, 3: 38-10.1186/1758-3284-3-38.PubMedCentralCrossRefPubMed
4.
go back to reference Wong BJ, Jackson RP, Guo S, Ridgway JM, Mahmood U, Su J, Shibuya TY, Crumley RL, Gu M, Armstrong WB, Chen Z: In vivo optical coherence tomography of the human larynx: normative and benign pathology in 82 patients. Laryngoscope. 2005 Nov, 115 (11): 1904-1911. 10.1097/01.MLG.0000181465.17744.BE.CrossRefPubMed Wong BJ, Jackson RP, Guo S, Ridgway JM, Mahmood U, Su J, Shibuya TY, Crumley RL, Gu M, Armstrong WB, Chen Z: In vivo optical coherence tomography of the human larynx: normative and benign pathology in 82 patients. Laryngoscope. 2005 Nov, 115 (11): 1904-1911. 10.1097/01.MLG.0000181465.17744.BE.CrossRefPubMed
5.
go back to reference Tsai MT, Lee HC, Lee CK, et al: Effective indicators for diagnosis of oral cancer using optical coherence tomography. Opt Express. 2008, 16: 15847-15862. 10.1364/OE.16.015847.CrossRefPubMed Tsai MT, Lee HC, Lee CK, et al: Effective indicators for diagnosis of oral cancer using optical coherence tomography. Opt Express. 2008, 16: 15847-15862. 10.1364/OE.16.015847.CrossRefPubMed
6.
go back to reference Tsai MT, Lee HC, Lu CW, et al: Delineation of an oral cancer lesion with swept-source optical coherence tomography. J Biomed Opt. 2008, 13: 044012-10.1117/1.2960632.CrossRefPubMed Tsai MT, Lee HC, Lu CW, et al: Delineation of an oral cancer lesion with swept-source optical coherence tomography. J Biomed Opt. 2008, 13: 044012-10.1117/1.2960632.CrossRefPubMed
7.
go back to reference Wilder-Smith P, Lee K, Guo S, Zhang J, Osann K: In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients. Lasers Surg Med. 2009b, 41: 353-357. 10.1002/lsm.20773.CrossRef Wilder-Smith P, Lee K, Guo S, Zhang J, Osann K: In vivo diagnosis of oral dysplasia and malignancy using optical coherence tomography: preliminary studies in 50 patients. Lasers Surg Med. 2009b, 41: 353-357. 10.1002/lsm.20773.CrossRef
8.
go back to reference Tsai MT, Lee CK, Lee HC, Chen HM, Chiang CP, Wang YM, Yang CC: Differentiating oral lesions in different carcinogenesis stages with optical coherence tomography. J Biomed Opt. 2009, 14: 044028-10.1117/1.3200936.CrossRefPubMed Tsai MT, Lee CK, Lee HC, Chen HM, Chiang CP, Wang YM, Yang CC: Differentiating oral lesions in different carcinogenesis stages with optical coherence tomography. J Biomed Opt. 2009, 14: 044028-10.1117/1.3200936.CrossRefPubMed
9.
go back to reference Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, Radhi H, Vourvachis M, El Maaytah M, Sandison A, Jay A, Hopper C: In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg. 2010 Jan, 48 (1): 18-25. 10.1016/j.bjoms.2009.04.019.CrossRefPubMed Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, Radhi H, Vourvachis M, El Maaytah M, Sandison A, Jay A, Hopper C: In vitro examination of suspicious oral lesions using optical coherence tomography. Br J Oral Maxillofac Surg. 2010 Jan, 48 (1): 18-25. 10.1016/j.bjoms.2009.04.019.CrossRefPubMed
10.
go back to reference Ridgway JM, Armstrong WB, Guo S, Mahmood U, Su J, Jackson RP, Shibuya T, Crumley RL, Gu M, Chen Z, Wong BJ: In vivo optical coherence tomography of the human oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg. 2006, 132: 1074-1081. 10.1001/archotol.132.10.1074.CrossRefPubMed Ridgway JM, Armstrong WB, Guo S, Mahmood U, Su J, Jackson RP, Shibuya T, Crumley RL, Gu M, Chen Z, Wong BJ: In vivo optical coherence tomography of the human oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg. 2006, 132: 1074-1081. 10.1001/archotol.132.10.1074.CrossRefPubMed
Metadata
Title
Structural validation of oral mucosal tissue using optical coherence tomography
Authors
Zaid Hamdoon
Waseem Jerjes
Raed Al-Delayme
Gordon McKenzie
Amrita Jay
Colin Hopper
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2012
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-4-29

Other articles of this Issue 1/2012

Head & Neck Oncology 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine